Bowles Neil E, Jou Chuanchau J, Arrington Cammon B, Kennedy Brett J, Earl Aubree, Matsunami Norisada, Meyers Lindsay L, Etheridge Susan P, Saarel Elizabeth V, Bleyl Steven B, Yost H Joseph, Yandell Mark, Leppert Mark F, Tristani-Firouzi Martin, Gruber Peter J
Department of Pediatrics, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah.
Nora Eccles Cardiovascular Research and Training Institute, Salt Lake City, Utah.
Am J Med Genet A. 2015 Dec;167A(12):2975-84. doi: 10.1002/ajmg.a.37297. Epub 2015 Aug 18.
Wolff-Parkinson-White (WPW) syndrome is a common cause of supraventricular tachycardia that carries a risk of sudden cardiac death. To date, mutations in only one gene, PRKAG2, which encodes the 5'-AMP-activated protein kinase subunit γ-2, have been identified as causative for WPW. DNA samples from five members of a family with WPW were analyzed by exome sequencing. We applied recently designed prioritization strategies (VAAST/pedigree VAAST) coupled with an ontology-based algorithm (Phevor) that reduced the number of potentially damaging variants to 10: a variant in KCNE2 previously associated with Long QT syndrome was also identified. Of these 11 variants, only MYH6 p.E1885K segregated with the WPW phenotype in all affected individuals and was absent in 10 unaffected family members. This variant was predicted to be damaging by in silico methods and is not present in the 1,000 genome and NHLBI exome sequencing project databases. Screening of a replication cohort of 47 unrelated WPW patients did not identify other likely causative variants in PRKAG2 or MYH6. MYH6 variants have been identified in patients with atrial septal defects, cardiomyopathies, and sick sinus syndrome. Our data highlight the pleiotropic nature of phenotypes associated with defects in this gene.
预激综合征(WPW)是室上性心动过速的常见病因,存在心脏性猝死风险。迄今为止,仅发现一个基因PRKAG2(编码5'-AMP激活蛋白激酶亚基γ-2)的突变是WPW的致病原因。通过外显子组测序分析了一个患有WPW的家族中五名成员的DNA样本。我们应用了最近设计的优先级排序策略(VAAST/家系VAAST)以及基于本体论的算法(Phevor),将潜在有害变异的数量减少到10个:还发现了一个先前与长QT综合征相关的KCNE2变异。在这11个变异中,只有MYH6 p.E1885K在所有受影响个体中与WPW表型共分离,且在10名未受影响的家庭成员中不存在。该变异经计算机方法预测具有损害性,且在千人基因组计划和美国国立卫生研究院心肺血液研究所外显子组测序项目数据库中均未出现。对47名无关的WPW患者组成的复制队列进行筛查,未在PRKAG2或MYH6中发现其他可能的致病变异。已在房间隔缺损、心肌病和病态窦房结综合征患者中发现了MYH6变异。我们的数据突出了与该基因缺陷相关的表型的多效性本质。